Published in:

01-11-2007 | CLINICAL CORRESPONDENCE

Severe cardiomyopathy in a patient with renal cell carcinoma after treatment with the novel tyrosine kinase inhibitor sunitinib

Authors: E. Chorianopoulos, D. Jäger*, H. A. Katus, N. Frey

Published in: Clinical Research in Cardiology | Issue 11/2007